Welcoming a New Board Member

The Myocarditis Foundation would like to welcome and introduce Michael Linn as the latest member of the Myocarditis Board of Directors!  Mr. Linn is a Regional Sales Manager for the Craniomaxillofacial division of the Stryker Corporation where he manages a team focused specifically on facial trauma/reconstruction and neurosurgery.   He has actively been involved with commercializing Stryker’s efforts in the cardiothoracic space, developing and launching products for sternal reconstruction in heart surgery patients.  He holds a BS from Bentley University, an MBA and an MS from Saint Peter’s University, and several certificates from Harvard University.

“As a longtime friend of a Viral Myocarditis survivor and heart transplant recipient, and a supporter of the Myocarditis Foundation, I have been able to learn extensively about the impact Myocarditis can have and the randomness of the disease state itself.  I believe passionately that the efforts of the foundation can serve as a catalyst to reduce such randomness, and work towards more preventative measures to predict and combat Myocarditis.”

Please join us in welcoming Mike to our Myocarditis Foundation Family and Board of Directors.  We know his youth and creative management style will expand the foundation’s influence for years to come.